Board Committee Changes
GlaxoSmithKline plc today announces the following change to its Board Committee membership effective 23 July 2021.
Dr Anne Beal has been appointed a member of the Audit & Risk Committee. This appointment is in addition to her membership of the Corporate Responsibility Committee.
V A Whyte
23 July 2021